Apolipoprotein B secretory regulation by degradation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 6, 2012, Pages 1334-1338

  Olofsson, Sven Olof ^a   Borén, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Atherosclerosis; Cell physiology; Lipoproteins

Indexed keywords

ALBUMIN; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; GLUCOSE REGULATED PROTEIN 78; HIGH DENSITY LIPOPROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OLEIC ACID; PROTEASOME; PROTEIN DISULFIDE ISOMERASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTERY WALL; ATHEROSCLEROSIS; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HEART MUSCLE; HUMAN; HYPERLIPIDEMIA; IMMUNOELECTRON MICROSCOPY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; RISK FACTOR;

ANIMALS; APOLIPOPROTEIN B-100; BIOMEDICAL RESEARCH; ENDOPLASMIC RETICULUM; GOLGI APPARATUS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LIPOPROTEINS, VLDL; MODELS, BIOLOGICAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 84861488671     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.251116     Document Type: Review

References (34)

1. Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J Clin Invest. 1998;101:1084-1093.
2. Borí J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest. 1998;101:2658-2664.
3. Tabas I, Williams KJ, Borí J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007;116:1832-1844.
4. Yang CY, Chen SH, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Li WH, Sparrow DA, DeLoof H, Rosseneu M. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 1986;323:738-742.
5. Alexander CA, Hamilton RL, Havel RJ. Subcellular localization of B apoprotein of plasma lipoproteins in rat liver. J Cell Biol. 1976;69:241-263.
6. Wettesten M, Bostrí K, Bondjers G, Jarfeldt M, Norfeldt PI, Carrella M, Wiklund O, Borí J, Olofsson SO. Pulse-chase studies of the synthesis of apolipoprotein B in a human hepatoma cell line, Hep G2. Eur J Biochem. 1985;149:461-466.
7. Bostrí K, Wettesten M, Borí J, Bondjers G, Wiklund O, Olofsson SO. Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells. J Biol Chem. 1986;261:13800-13806.
8. Bostrí K, Borí J, Wettesten M, Sjérg A, Bondjers G, Wiklund O, Carlsson P, Olofsson SO. Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells. J Biol Chem. 1988;263:4434-4442.
9. Tsai J, Qiu W, Kohen-Avramoglu R, Adeli K. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly. Arterioscler Thromb Vasc Biol. 2007;27:211-218.
10. Borí J, Wettesten M, Rustaeus S, Andersson M, Olofsson SO. The assembly and secretion of apoB-100-containing lipoproteins. Biochem Soc Trans. 1993;21:487-493.
11. Davis RA, Boogaerts JR. Intrahepatic assembly of very low density lipoproteins. Effect of fatty acids on triacylglycerol and apolipoprotein synthesis. J Biol Chem. 1982;257:10908-10913.
12. Pullinger CR, North JD, Teng BB, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989;30:1065-1077.
13. Borchardt RA, Davis RA. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion. J Biol Chem. 1987;262:16394-16402.
14. Davis RA, Thrift RN, Wu CC, Howell KE. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools. J Biol Chem. 1990;265:10005-10011.
15. Sparks JD, Sparks CE. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem. 1990;265:8854-8862.
16. Sato R, Imanaka T, Takatsuki A, Takano T. Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment. J Biol Chem. 1990;265:11880-11884.
17. Dixon JL, Furukawa S, Ginsberg HN. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 1991;266:5080-5086.
18. Pape ME, Castle CK, Murray RW, Funk GM, Hunt CE, Marotti KR, Melchior GW. Apo B metabolism in the cynomolgus monkey: evidence for posttranscriptional regulation. Biochim Biophys Acta. 1991;1086:326-334.
19. Siuta-Mangano P, Howard SC, Lennarz WJ, Lane MD. Synthesis, processing, and secretion of apolipoprotein B by the chick liver cell. J Biol Chem. 1982;257:4292-4300.
20. Borí J, Graham L, Wettesten M, Scott J, White A, Olofsson SO. The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins. J Biol Chem. 1992;267:9858-9867.
21. Rustaeus S, Stillemark P, Lindberg K, Gordon D, Olofsson SO. The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McARH7777 cells. J Biol Chem. 1998;273:5196-5203.
22. Fisher EA, Ginsberg HN. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem. 2002;277:17377-17380.
23. Borí J, Rustaeus S, Wettesten M, Andersson M, Wiklund A, Olofsson SO. Influence of triacylglycerol biosynthesis rate on the assembly of apoB-100-containing lipoproteins in Hep G2 cells. Arterioscler Thromb. 1993;13:1743-1754.
24. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51-F58.
25. Schmidtke G, Holzhäter HG, Bogyo M, Kairies N, Groll M, de Giuli R, Emch S, Groettrup M. How an inhibitor of the HIV-I protease modulates proteasome activity. J Biol Chem. 1999;274:35734-35740.
26. Liang JS, Distler O, Cooper DA, Jamil H, Deckelbaum RJ, Ginsberg HN, Sturley SL. HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitorinduced hyperlipidemia. Nat Med. 2001;7:1327-1331.
27. Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J Biol Chem. 2001;276:27855-27863.
28. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest. 2004;113:1277-1287.
29. Pan M, Maitin V, Parathath S, Andreo U, Lin SX, St Germain C, Yao Z, Maxfield FR, Williams KJ, Fisher EA. Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control. Proc Natl Acad Sci USA. 2008;105:5862-5867.
30. Fisher EA, Williams KJ. Autophagy of an oxidized, aggregated protein beyond the ER: a pathway for remarkably late-stage quality control. Autophagy. 2008;4:721-723.
31. Brodsky JL, Fisher EA. The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol Metab. 2008;19:254-259.
32. Sparks JD, Phung TL, Bolognino M, Sparks CE. Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes. Biochem J. 1996;313 (Pt 2):567-574.
33. Williams KJ, Brocia RW, Fisher EA. The unstirred water layer as a site of control of apolipoprotein B secretion. J Biol Chem. 1990;265: 16741-16744.
34. Olofsson SO, Bostrí P, Andersson L, Rutberg M, Perman J, Borí J. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta. 2009;1791:448-458.